$SSFT (copy) **** $SSFT DD/RESEARCH POST **** Posted to

New Post Public Reply Private Reply Replies (0) Message Board
mc67
1,071
$SSFT (copy) **** $SSFT DD/RESEARCH POST ****

Posted to Reddit today

Sonasoft $SSFT – Fully Audited AI Company with $13.33M revenues and deals with $FIS and $GOOGL


Sonasoft $SSFT) Overview/ Research/ DD

Looks like SSFT has been picking up steam the last month. Figured I’d throw out some quick ‘Coles-notes’ style DD for anyone to get started research.

Point form Notes:

- SSFT founded in 2003 in Silicon Valley

- Services a wide-range of household named clients like Amazon, Nvidia, TiVO, VISA, etc. source: https://sonasoft.com/about/our-clients/

- Shifted primary focus to Artificial Intelligence (AI) in 2019 with the acquisition of Hotify, Inc, the creator of NuGene AI. https://www.otcmarkets.com/stock/SSFT/news/So...?id=225956

June 2020: Sonasoft quietly submitted 2 huge SEC 8-K filings. 1) deal with $FIS for the development of AI solutions, and 2) deal with Google to develop Google Cloud Learning Systems

FIS - https://www.otcmarkets.com/filing/html?id=141...qJE71_MX3h

GOOGL - https://www.otcmarkets.com/filing/html?id=142...qJE71_MX3h

(Both Google and FIS would have APPROVED these filings)

July 2020: Sonasoft (SSFT) Reports full-year 2019 Audited Revenue of $13.33 Million; an Increase of 1260% YoY; First Quarter 2020 Revenue of $2.8 Million; an Increase of 47% YoY

https://www.otcmarkets.com/stock/SSFT/news/So...?id=268275

Points of interest: After the Google and FIS filings, SSFT did NOT put out formal PR’s pumping the deals etc. Most OTC stocks would have never shut up about huge named deals like that. Why did they stay so quiet?

Well, it would seem they are more concerned with building the business/company than pumping their stock. Breath of fresh air. They would have most likely had to file NDA’s with those giant companies and also they would want to keep their dealings under the radar as to not tipoff the competition (my views)

After the 8-K filings and subsequent Audited $13.33M in revenue announcements, the Company went silent and the stock flew under the radar for months despite the huge deals in the works.

Finally, on Dec 30, 2020: SSFT provided annual update which described its AI tech, its strengthened AI Engineering and Management teams**, a deal with a “multi-billion-dollar financial services company”,** and I think possibly most importantly – Announced they had filed a patent to protect their Intellectual Property relating to their AI tech.

The patent filings as well as the deal with the multi-billion-dollar financial services firm (I am assuming that is $FIS) explains why the Company was so quiet over the past 6+ months. They were working on a huge deal with cutting-edge technology – both of which needed to be kept quiet to protect the deal (my opinion obviously)

Following the December 30 announcements, the market began to slowly catch on and trading volumes and price started to really pick up. Sentiment and interest on message board has significantly increased as well.

Then, most recently on January 28th 2021 – SSFT announced yet another key patent filed for its AI tech. Once again strengthening their position and protecting/increasing shareholder value even more.

https://www.otcmarkets.com/stock/SSFT/news/So...?id=287849

Share Structure:

SSFT has done a fantastic job raising capital to drive growth while simultaneously protecting shareholder value. They have NO toxic debt. The majority of shares are held by insiders and long-term shareholders. One investor alone Dr. R Japra owns 33% of the outstanding share count** (baller). (** source PAGE 13 https://backend.otcmarkets.com/otcapi/company...75/content

Market cap (02-04-2021) 76,734,996

Outstanding Shares 485,664,531

Float 229,925,241

https://www.otcmarkets.com/stock/SSFT/security

Moving Forward:

So, what is next for SSFT? Well, investors are speculating we could be waiting on details relating to the Google or FIS deals, further patents, or new deals with other big named companies (they already have a long list of big named clients).

Further, the fact that FIS and Google chose SSFT as their AI tech provider speaks volumes about the efficacy of the tech. And now this tech is in the process of becoming IP protected / Patented which could add significant value to the company.

In previous Press Releases, the company has mentioned intentions to up-list to higher exchanges (Nasdaq) and also that the steps it is taking would make SSFT an attractive buyout candidate by a larger company.

The RedHat buyout by IBM comes to mind from a couple years ago. Investors woke up one morning to learn that RedHat was getting acquired for $34 Billion

https://www.cnbc.com/2019/07/09/ibm-closes-it...d-hat.html

With the current climate in the OTC Markets and stock market in general with companies like AITX and TSNP running up to hundreds of million $ and even BILLION $ market caps (while having BILLIONS of shares outstanding) – I think $SSFT with their relatively tight share structure, $13M+ audited revs, and huge current deals with major companies has a great shot at running into the dollars from its current price of 0.18/share.

Of course, DO NOT take my word for anything. I’m just pointing out what I like / think and my opinions. I am just letting people know they might want to investigate this one and do some DD/Research.

I welcome any thoughts / feedback.

Thanks for reading. I truly hope you all make tons of $$$

Sources:

https://www.otcmarkets.com/stock/SSFT/overview

https://www.otcmarkets.com/stock/SSFT/profile

https://www.otcmarkets.com/stock/SSFT/news

https://www.otcmarkets.com/stock/SSFT/disclosure

https://sonasoft.com/

Sonasoft Corp. (SSFT) Stock Research Links

SSFT Board Company Profile Buy Rating Time & Sales News Filings Financials
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

RION Completes Patient Enrollment for Innovative Diabetic Ulcer Study

Updated Category News Views 180

RION Completes Patient Enrollment for Innovative Diabetic Ulcer Study RION, a pioneering clinical-stage company focused on regenerative medicine, has reached a significant milestone by completing patient enrollment in its Phase 2 clinical trial for the Purified Exosome Product™ (PEP™). This innovative study aims to tackle the pressing problem of diabetic foot ulcers...

Continue Reading
Empowering Mental Health: BrainsWay's CME Course Initiative

Updated Category News Views 114

BrainsWay Leads in TMS Education Through Free CME Courses BURLINGTON, Mass. and JERUSALEM, Israel — BrainsWay, a leader in noninvasive neurostimulation treatments, is excited to announce its sponsorship of two free Continuing Medical Education (CME) courses. These courses aim to enhance mental health professionals' understanding and application of Transcranial Magnetic...

Continue Reading
OCCIN Reaches New Heights as Stock Surges to $23.52

Updated Category News Views 55

OCCIN Stock Hits New Heights In a notable market development, shares of OFS Credit Company (NASDAQ: OCCI) Inc. (OCCIN) have soared to an impressive 52-week high, reaching $23.52. This significant achievement reflects the steady upward trend of the investment firm, which primarily focuses on collateralized loan obligations. Over the last year, OCCIN's stock has shown...

Continue Reading
Rapid Micro Biosystems Plans Financial Results Announcement

Updated Category News Views 88

Rapid Micro Biosystems to Report Fourth Quarter Financials Rapid Micro Biosystems, Inc. (NASDAQ: RPID), a pioneering force in life sciences technology, is gearing up to unveil its fourth quarter and full-year financial outcomes for 2024. This milestone is set to take place on February 28, 2025, before the stock market opens, reflecting the company's commitment to...

Continue Reading
Bekaert's Latest Developments in Share Buyback and Liquidity

Updated Category News Views 337

Update on Share Buyback Program The share buyback journey continues for Bekaert with exciting developments outlined in their latest announcement. Recently, a significant milestone was reached as the company initiated a new tranche of its share buyback program. The aim of this program is clear: to enhance shareholder value by reducing the total number of outstanding...

Continue Reading